Supernus, Inc. to Participate in the 2026 Jefferies Global Healthcare Conference in London
Supernus announced that it will participate in the 2026 Jefferies Global Healthcare Conference in London. The excerpt identifies the company as a biopharmaceutical business focused on developing and commercializing products for CNS diseases.
Why it matters — The conference participation is an update on Supernus’s investor and industry engagement.